The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
Ben Middelkamp is a communications manager for the Department of Neurology, Department of Neurological Surgery and Stark Neurosciences Research Institute at Indiana University School of Medicine. Before joining the Office of Strategic Communications in December 2019, Ben spent nearly six years as a newspaper reporter in two Indiana cities. He earned a bachelor’s degree in Convergent Journalism from Indiana Wesleyan University in 2014. Ben enjoys translating his background in journalism to the communications and marketing needs of the school and its physicians and researchers.
Three Indiana University School of Medicine researchers each received National Institutes of Health grant funding to study under-explored mechanisms and connections in the brain using animal models. Through their investigations, they hope to discover therapeutic targets to treat health conditions, including obesity, anxiety and alcohol use disorder. The faculty investigators are members of the addiction research interest group at Stark Neurosciences Research Institute.
Glick Eye Institute researchers Arupratan Das, PhD, Padmanabhan Pattabiraman, PhD, Weiming Mao, PhD and Tasneem Sharma, PhD—also members of the ocular neurobiology research interest group at Stark Neurosciences Research Institute— are exploring ways to prevent and treat the disease.
Neurologists at Indiana University School of Medicine are among the first clinicians in the nation to administer a groundbreaking gene-based therapy for patients living with a rare form of amyotrophic lateral sclerosis (ALS).
For nearly a decade, lecanemab has been tested in clinical trials at IU School of Medicine. The drug targets the removal of amyloid plaques in the brain—a hallmark of Alzheimer’s disease. Over the past few months, nearly a dozen patients have received the treatment, which is administered through intravenous infusions every two weeks at the IU Health Neuroscience Center in downtown Indianapolis.
The Alzheimer’s Association recently named Kate Foley, PhD, postdoctoral fellow in the Department of Neurology at Indiana University School of Medicine, as the inaugural Dr. Mel Perelman Fellow for Alzheimer’s Research.
This research fellowship, named in honor of the late Mel Perelman, PhD, a former executive of Eli Lilly and Company, will be awarded annually to an IU School of Medicine researcher who has been vetted and selected by the Alzheimer’s Association’s Medical and Scientific Advisory Group to receive a research grant.
Robert B. Sloan, MD, looks back on his time at Indiana University fondly. The Indianapolis physician spent his entire higher education career at IU. He earned his bachelor’s degree at IU-Bloomington and completed his medical degree and residency at IU School of Medicine. Sloan, who is the sole neurosurgeon at Community Hospital East, carried out the bulk of that time at IU studying medicine, specifically neurosurgery as a resident in the Department of Neurological Surgery from 2000-2006.
The Department of Otolaryngology—Head and Neck Surgery is hosting the Inaugural Allison K. Royer Women in Otolaryngology Endowed Lectureship on March 22, 2023, at IU School of Medicine in Indianapolis. It is one of the first women in otolaryngology endowed lectureships in the country.
Thanks to the generosity of donors, the department established the Edward C. Weisberger Fellowship in Head and Neck Oncology and Reconstructive Surgery and Lectureship. The endowed lectureship, which had its inaugural seminar in fall 2022, enables the department to bring prominent physicians to campus to share their expertise in head and neck surgery.